News

Meet Monika Matucza, Head of Bulk Production

Thursday 9th April 2020

News Image

Dedication and expertise are key qualities necessary to provide flexible solutions to our customers, and we are lucky to have an expert group supporting our #ContractManufacturing efforts. Our colleagues will be sharing their insights into pharmaceutical manufacturing and how they make the most of Acino’s state-of-the-art facilities to contribute to our customers’ #outsourcing strategy.

Meet Monika Matucza, Head of Bulk Production.

Monika leads Acino’s Bulk Production plants in Aesch and Liesberg, Switzerland. She works closely with our Contract Manufacturing team servicing B2B customers with best-in-class drug-delivery solutions for oral solid dosage forms.

We asked Monika to share some insights into her daily work and the challenges she faces, especially in light of the current Covid-19 crisis.

Learn more about Acino’s bulk production.

Q: Which processes are you responsible for or involved in?

I am responsible for the whole production process from the dispensing of raw materials to the final dosage form, which in our case is the granule, pellet, tablet, film-coated tablet or capsule.

Some of my daily activities include ensuring the on-time production of medicines under the highest quality standards, leading projects and audits, personnel management and operator training.

Q: How do you ensure that these processes run smoothly during a crisis such as Covid-19? 

The short answer is by implementing and respecting standard operating procedures and by providing specialized and continuous training to our production colleagues.

Communication and smoothly running processes are more important than ever. With many support functions of production working remotely it is important to make sure information gets to everyone on time and with the correct content.

For me as a leader it is essential that my employees know that I am always reachable if they have any questions of concerns as everyone is also struggling with personal uncertainties.

Our main focus is still to keep production running on a high level to supply our markets and customers with vital medication.

Q: What are the challenges you face in your daily work and how do you handle them?

The biggest challenge we all are facing is that we are living an unprecedented situation with Covid-19. For us this means that we need to continue to supply medicines to patients despite increasingly challenging and changing conditions sourcing raw materials and finding logistic solutions while ensuring the well-being and safety of our colleagues who need to come to work.

Many projects running simultaneously need to be executed on time. In order to do that I aim to always optimize and structure my own work and give the best support to my teams and others.

Q: What do you love the most about your job?

What I love the most is the diversity of tasks and the opportunity to learn new things. Moreover, I also appreciate working with people at different professional levels across the company.

Q: What makes you proud of Acino?

We have an ambitious growth plan and strive to make medicines accessible to patients and healthcare professionals in emerging markets. Playing a key role in this makes me proud.

Q: What do you like the most about Bulk’s contribution Acino’s B2B activities?

I like seeing all the new products running on our production lines. I love to see a lot of movement when walking through the plant.

Connect with Monika on LinkedIn.

Although we had to stop site tours for a while to help with social distancing and maintain the safety of our colleagues who must keep production running during the Covid-19 crisis, you can still visit our Liesberg site virtually.